Patent · US Active

Compositions for inhibiting MASP-2 dependent complement activation

US9011860B2 · kind B2 · utility

8Cited by

18References

24Claims

0Family size

Assignee

Omeros Corporation · US

Inventors

Thomas Dudler · Bellevue, US
Wayne R. Gombotz · Kenmore, US
James Brian Parent · Bainbridge Island, US
Clark E. Tedford · Poulsbo, US
Anita Kavlie · Oslo, NO
Urs Beat Hagemann · Oslo, NO
Herald Reiersen · Sofiemyr, NO
Sergej Kiprijanov · Oslo, NO

Key dates

Filing date	May 4, 2012
Grant date	Apr 21, 2015
Priority date	—
Expiry date	May 4, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-2 dependent complement activation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.